1995
DOI: 10.1583/1074-6218(1995)002<0081:egfpae>2.0.co;2
|View full text |Cite
|
Sign up to set email alerts
|

Endoluminal Grafting for Percutaneous Aneurysm Exclusion in an Aortocoronary Saphenous Vein Graft: The First Clinical Experience

Abstract: In this patient with limited therapeutic options, percutaneous aneurysm exclusion in an SVG was effective in restoring a viable blood conduit. It remains to be seen if ELGs have a potential in aortocoronary SVGs.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
8
0

Year Published

1996
1996
2019
2019

Publication Types

Select...
8

Relationship

8
0

Authors

Journals

citations
Cited by 38 publications
(8 citation statements)
references
References 20 publications
0
8
0
Order By: Relevance
“…In the report by Ellis and colleagues [6], it is suggested that class-3 perforations with free extravasation of dye and early tamponade should all be managed operatively. Recently, the use of autologous saphenous vein grafts sewn to stents has been reported to be effective in sealing perforations [7,8], while we have reported the successful implantation of an endoluminal graft composed of expanded polytetrafluoroethylene sewn to a Palmaz stent in a similar application [9].…”
Section: Discussionmentioning
confidence: 86%
“…In the report by Ellis and colleagues [6], it is suggested that class-3 perforations with free extravasation of dye and early tamponade should all be managed operatively. Recently, the use of autologous saphenous vein grafts sewn to stents has been reported to be effective in sealing perforations [7,8], while we have reported the successful implantation of an endoluminal graft composed of expanded polytetrafluoroethylene sewn to a Palmaz stent in a similar application [9].…”
Section: Discussionmentioning
confidence: 86%
“…In our case the CAA was wide in diameter and long in length, and we felt that a covered stent would be more appropriate. In addition, IVUS [14,15] may have been useful in this setting to define whether this was a true aneurysm or pseudoaneurysm; however, with the increasing size of the aneurysm, symptoms, and documentation of ischemia, treatment would have still been necessary. Other options for CAA include coronary artery bypass surgery (CABG) with aneurysm resection [16]; however, with singlevessel coronary disease, we preferred to treat this nonsurgically.…”
Section: Discussionmentioning
confidence: 99%
“…We first introduced the concept of the polytetrafluoroethylene (PTFE)‐covered stent in Phoenix 25 years ago. In 1993, we successfully treated a complex aneurysmal lesion in a saphenous vein graft, which was causing ischemic symptoms, by creating a mechanical barrier to seal the aneurysm by preparing the stent graft with commercially available PTFE, and a commercially available Palmaz stent . Dr. Christodoulos Stefanadis also designed the application of a biological covered stent in which the metallic surface was covered by an autologous venous graft .…”
mentioning
confidence: 99%